Implication of von willebrand factor as a regulator of tumor cell metastasis: Potential perioperative use of desmopressin and novel peptide analogs

Acta Haematologica

Volumn 129, Issue 4, 2013, Pages 223-224

  Ripoll, Giselle V ^a   Alonso, Daniel F ^a  

^a UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; VON WILLEBRAND FACTOR; 1 DEAMINO 4 VALINE 5 GLUTAMINE 8 DEXTRO ARGININE VASOPRESSIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VASOPRESSIN V2 RECEPTOR;

BLEEDING; BREAST CANCER; CANCER CELL; CELL SURVIVAL; DRUG MEGADOSE; HUMAN; LETTER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; METASTASIS; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; VON WILLEBRAND DISEASE; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER SURGERY; CAPILLARY ENDOTHELIAL CELL; OVERALL SURVIVAL; PROPHYLAXIS; SHORT COURSE THERAPY; TUMOR MICROENVIRONMENT;

ANIMALS; HEMOSTASIS; HUMANS; VON WILLEBRAND FACTOR;

EID: 84871856959     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000346071     Document Type: Letter

References (10)

1. Luo GP, Ni B, Yang X, Wu YZ: von Willebrand factor: more than a regulator of hemostasis and thrombosis. Acta Haematol 2012; 128: 158-169.
2. Terraube V, Pendum R, Baruch D, Gebbink MF, Meyer D, Lenting PJ, Denis CV: Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice. J Thromb Haemost 2006; 4: 517-528.
3. Mochizuki S, Soejima K, Shimoda M, Abe H, Sasaki A, Okano HJ, Okano H, Okada Y: Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor. J Natl Cancer Inst 2012; 104: 906-922.
4. Alonso DF, Skilton G, Farias EF, Bal de Kier Joffe E, Gomez DE: Antimetastatic effect of desmopressin in a mouse mammary tumor model. Breast Cancer Res Treat 1999; 57: 271-275.
5. Giron S, Tejera AM, Ripoll GV, Gomez DE, Alonso DF: Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation. J Surg Oncol 2002; 81: 38-44.
6. Kaufman JE, Vischer UM: Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost 2003; 1: 682-689.
7. Hermo GA, Torres P, Ripoll GV, Scursoni AM, Gomez DE, Alonso DF, Gobello C: Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: a pilot study. Vet J 2008; 178: 103-108.
8. Hermo GA, Turic E, Angelico D, Scursoni AM, Gomez DE, Gobello G, Alonso DF: Effect of adjuvant perioperative desmopressin in locally-advanced canine mammary carcinoma and its relation to histological grade. J Amer Anim Hosp Assoc 2011; 47: 21-27.
9. Alonso DF, Ripoll GV, Garona J, Iannucci NB, Gomez DE: Metastasis: recent discoveries and novel perioperative treatment strategies with particular interest in the hemostatic compound desmopressin. Curr Pharm Biotechnol 2011; 12: 1974-1980.
10. Iannucci NB, Ripoll GV, Garona J, Cascone O, Ciccia GN, Gomez DE, Alonso DF: Antiproliferative effect of 1-deamino-8-D-arginine vasopressin analogs on human breast cancer cells. Fut Med Chem 2011; 3: 1987-1993.